Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
61.42 USD | +1.25% | +3.00% | +52.33% |
May. 07 | Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating | MT |
May. 07 | Oppenheimer Adjusts RxSight Price Target to $72 From $61, Maintains Outperform Rating | MT |
Financials (USD)
Sales 2024 * | 135M | Sales 2025 * | 181M | Capitalization | 2.26B |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -18M | EV / Sales 2024 * | 15.9 x |
Net cash position 2024 * | 101M | Net cash position 2025 * | 107M | EV / Sales 2025 * | 11.9 x |
P/E ratio 2024 * |
-74
x | P/E ratio 2025 * |
-122
x | Employees | 374 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.68% |
Latest transcript on RxSight, Inc.
1 day | +1.25% | ||
1 week | +3.00% | ||
Current month | +17.82% | ||
1 month | +11.45% | ||
3 months | +23.41% | ||
6 months | +158.07% | ||
Current year | +52.33% |
Managers | Title | Age | Since |
---|---|---|---|
Ronald Kurtz
CEO | Chief Executive Officer | 60 | 15-05-31 |
Shelley Thunen
DFI | Director of Finance/CFO | 72 | 15-12-31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Palmisano
BRD | Director/Board Member | 79 | 21-08-09 |
Bill Link
BRD | Director/Board Member | 78 | 16-10-31 |
Ronald Kurtz
CEO | Chief Executive Officer | 60 | 15-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +9.11% | - | |
0.00% | 0 M€ | +3.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 60.66 | -2.46% | 413,981 |
24-05-07 | 62.19 | -1.03% | 607,967 |
24-05-06 | 62.84 | +1.88% | 588,771 |
24-05-03 | 61.68 | +3.44% | 532,855 |
24-05-02 | 59.63 | +5.17% | 651,363 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.33% | 2.26B | |
-4.91% | 183B | |
+0.46% | 108B | |
-3.62% | 67.51B | |
+3.26% | 50.67B | |
+9.11% | 44.7B | |
+2.41% | 40.95B | |
+6.39% | 26.8B | |
+3.83% | 26.71B | |
+12.66% | 24.62B |
- Stock Market
- Equities
- RXST Stock